No Negative Psychological Impact Seen for Disclosing Aβ Status
FRIDAY, May 9, 2025 -- Disclosure of amyloid-β (Aβ) status seems not have a negative psychological impact, according to a study published online May 7 in Alzheimer's & Dementia.
Sapir Golan Shekhtman, from Sheba Medical Center in Ramat Gan, Israel, and colleagues examined emotional responses to Aβ status disclosure in cognitively normal individuals. To assess anxiety and depression associated with an elevated result, subjective memory complaints, and motivation for risk-reduction behavior, questionnaires were administered before and six months after disclosure of Aβ positron emission tomography (PET) results. Data were included for 199 cognitively normal adults.
The researchers observed reductions in all emotional parameters in association with nonelevated Aβ status disclosure relative to baseline. No changes in depression or memory complaints were seen in association with elevated Aβ disclosure, while there was a modest decrease in anxiety and motivation to change lifestyle.
"Our findings suggest no psychological harm in elevated and nonelevated Aβ PET scan status disclosure, strengthening findings from previous studies," the authors write. "The decrease in motivation to implement lifestyle changes after the disclosure of elevated or nonelevated Aβ status warns against false reassurance during the disclosure process."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Skin-to-Skin Contact Boosts Brain Growth in Very Preterm Infants
WEDNESDAY, Oct. 1, 2025 -- Skin-to-skin contact is linked to brain growth in very preterm infants, according to a study published online Sept. 24 in Neurology. Katherine E...
Self-Reported Cognitive Disability Rates Increased in U.S. Adults From 2013 to 2023
TUESDAY, Sept. 30, 2025 -- Rates of self-reported cognitive disability rose in U.S. adults from 5.3 to 7.4 percent in the last decade, particularly among younger adults, according...
Odds of Repeat Imaging Higher for Nonphysician Practitioner Interpretation
TUESDAY, Sept. 30, 2025 -- Imaging studies are more likely to be repeated within 90 days when the initial study is interpreted by a nonphysician practitioner (NPP) than when...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.